9th Annual Hematology and Medical Oncology Board Review: Contemporary Practice

9th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Video Lectures

This four day virtual course will provide an up-to-date and

comprehensive review of the diagnosis, staging, and

management of neoplastic disease, including

solid tumor and hematologic oncology

Lectures will focus on disease specific topics in gastrointestinal,

gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin,

and central nervous system oncology, as well as hematologic oncology.

By attending this board review, attendees will:

• Learn state-of-the-science in diagnosis, staging, and therapeutic

management of solid tumor cancers

• Learn state-of-the-science in diagnosis, staging, and therapeutic

management of hematologic cancers

• Understand recent treatment advances in solid tumor and

hematologic oncology and their impact on modern clinical practice

This board review course is intended for medical oncology professionals,

including physicians, nurses, pharmacists, fellows, and residents.

MSK Course Directors

David H. Ilson, MD, PhD

Attending Physician, Gastrointestinal Oncology Service

Division of Solid Tumor Oncology

Department of Medicine

Member, Memorial Sloan Kettering Cancer Center

Professor of Medicine, Weill Cornell Medical College

This four day virtual course will provide an up-to-date and

comprehensive review of the diagnosis, staging, and

management of neoplastic disease, including

solid tumor and hematologic oncology.

Paul A. Hamlin, MD

Medical Director, David H. Koch Center for Cancer Care

Associate Attending, Lymphoma Service

Division of Hematologic Malignancies

Department of Medicine

Associate Professor of Medicine, Weill Cornell Medical College

Attendees will receive access to an online syllabus,

which includes PDFs of the slides and recorded

videos of the presentations.

CONTENT

6:45 am Virtual Course Check-in

7:00 am Welcome and Introduction Paul A. Hamlin, MD

7:05 am Pharmacology Mrinal M. Gounder, MD

9:20 am Break

9:30 am CAR T cells Renier J. Brentjens, MD, PhD

10:30 am Low Grade NHL Andrew D. Zelenetz, MD, PhD

11:00 am CLL/SLL Anthony Mato, MD

11:30 am DLBCL/MCL/BL Paul Hamlin, MD

12:30 pm Lunch Break

1:15 pm HL/T Cell Alison Moskowitz, MD

2:15 pm Auto/Allo Craig Sauter, MD

3:15 pm AML/ALL Martin S. Tallman, MD

4:15 pm Break

4:45 pm MDS/MPN Michael J. Mauro, MD

5:45 pm Myeloma/Amyloid Malin Hultcrantz, MD, PhD

6:15 pm Closing Remarks and Adjourn Paul A. Hamlin, MD

7:45 am Virtual Course Check-in

8:00 am Welcome and Introduction Paul A. Hamlin, MD

8:05 am Approach to The Bleeding Patient Rekha Parameswaran, MD

9:00 am The Role of the New Direct Oral

Anticoagulants in Practice

Simon Mantha, MD, MPH

10:00 am Thrombocytopenia, ITP and Beyond Cy Wilkins, MD

11:00 am Sickle Cell Disease, Thalassemia Jodi Mones, MD

12:00 pm Closing Remarks and Adjourn Paul A. Hamlin, MD